Skip to main content
    I

    Inspire Veterinary Partners, Inc. Class A Common Stock (IVP)

    Official site

    PERSONAL SERVICES

    $0.03
    +0.00 (+0.00%)

    Last updated: Nov 06, 2026 at 4:00 PM ET

    Inspire Veterinary Partners, Inc. Class A Common Stock (IVP) Financials: Revenue, Profit and Cash Flow

    Updated Nov 12, 2025. Financial statements from company filings, amounts in US dollars.

    Inspire Veterinary Partners, Inc. Class A Common Stock reported revenue of $16.59M for the fiscal year ended Dec 31, 2024, down 0.5% from the year before. That year, net income was -$14.26M with a net margin of -86.0%, operating cash flow was -$10.01M and free cash flow was -$10.24M. The quarter ended Sep 30, 2025 had revenue of $4.32M and net income of -$2.53M.

    Revenue and Margins

    The operating margin was -54.4% in the fiscal year ended Dec 2024, the lowest of the 4 years shown with an operating margin.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2024$16.59M-0.5%19.8%-54.4%-86.0%
    Dec 2023$16.68M+69.6%21.3%-43.0%-88.7%
    Dec 2022$9.83M+285.8%25.9%-35.8%-49.9%
    Dec 2021$2.55MN/A32.5%-41.1%-52.2%
    Dec 2020N/AN/AN/AN/AN/A
    Annual, fiscal years ended Dec 2020 to Dec 2024

    Income Statement

    In the fiscal year ended Dec 2024, the net loss narrowed from the year before. In the quarter ended Sep 2025, the net loss narrowed from the same quarter a year earlier.

    Annual

    Line itemDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
    Revenue$16.59M$16.68M$9.83M$2.55MN/A
    Cost of revenue$13.30M$13.12M$7.29M$1.72MN/A
    Gross profit$3.29M$3.55M$2.55M$829.29KN/A
    Operating income-$9.03M-$7.17M-$3.52M-$1.05M-$5.52K
    Net income-$14.26M-$14.79M-$4.91M-$1.33M-$5.52K
    EBITDAN/AN/A-$2.91M-$977.46KN/A
    Fiscal years ended Dec 2020 to Dec 2024

    Quarterly

    Line itemSep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022
    Revenue$4.32M$4.28M$3.64M$3.32M$4.05M$4.39M$4.83M$3.78M$4.12M$4.49M$4.28M$3.18M
    Gross profit$1.64M$1.85M$714.52K$534.57K$626.02K$1.03M$1.11M-$194.67K$1.06M$1.26M$1.10M$640.04K
    Operating income-$1.97M-$2.62M-$2.01M-$1.54M-$2.24M-$2.39M-$2.86M-$2.42M-$2.83M-$932.97K-$1.00M-$1.35M
    Net income-$2.53M-$3.03M-$2.42M-$3.97M-$3.49M-$3.39M-$3.42M-$4.14M-$7.88M-$1.23M-$1.54M-$1.93M
    Last 12 quarters

    Balance Sheet

    As of Dec 2024, total debt of $14.43M exceeded cash and equivalents by $13.90M.

    Annual

    Line itemDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
    Total assets$20.20M$21.79M$20.19M$6.33M$21.97K
    Current assets$2.02M$1.35M$1.74M$2.39M$21.97K
    Cash and equivalents$523.69K$178.96K$444.25K$2.06M$21.97K
    Total liabilities$18.63M$22.58M$25.32M$7.20MN/A
    Short-term debt$5.93M$3.42M$5.54M$1.50MN/A
    Long-term debt$8.49M$13.48M$17.41M$5.20MN/A
    Shareholder equity$1.56M-$788.26K-$5.14M-$869.09K$21.97K
    Fiscal years ended Dec 2020 to Dec 2024

    Quarterly

    Line itemSep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022
    Total assets$23.96M$20.81M$20.66M$20.20M$22.40M$21.93M$23.40M$21.79M$21.30M$20.02M$20.05M$20.19M
    Total liabilities$19.79M$20.36M$17.66M$18.63M$19.37M$25.04M$23.13M$22.58M$18.58M$27.92M$26.73M$25.32M
    Cash and equivalents$341.75K$158.94K$1.74M$523.69K$681.20K$7.66K$69.08K$178.96K$1.96M$863.18K$593.87K$444.25K
    Shareholder equity$4.17M$446.26K$3.00M$1.56M$3.03M-$3.11M$269.85K-$788.26K$2.71M-$7.90M-$6.67M-$5.14M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2024.

    Annual

    Line itemDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
    Operating cash flow-$10.01M-$3.82M-$2.66M-$1.01M-$5.52K
    Capital expenditures$237.98K$383.73K$176.79K$1.31M$1.31M
    Free cash flow-$10.24M-$4.20M-$2.84M-$2.32M-$1.32M
    Dividends paid$92.32K$271.25KN/AN/AN/A
    Investing cash flow-$237.98K-$1.87M-$14.67M-$4.02M-$4.02M
    Financing cash flow$10.59M$5.63M$15.71M$7.07M$269.16K
    Fiscal years ended Dec 2020 to Dec 2024

    Quarterly

    Line itemSep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022
    Operating cash flow-$1.28M-$898.28K-$1.37M-$677.53K-$6.31M$149.72K-$3.17M-$754.78K-$2.56M-$197.50K-$309.45K-$340.38K
    Capital expenditures$43.47K$12.58K$20.27K$31.83K$25.52K$23.69K$156.94K$19.63K$240.55K$109.55K$14.00K$3.32M
    Free cash flow-$1.33M-$910.86K-$1.39M-$709.36K-$6.33M$126.03K-$3.33M-$774.41K-$2.80M-$307.05K-$323.46K-$3.66M
    Last 12 quarters

    Frequently Asked Questions About IVP

    What is Inspire Veterinary Partners, Inc. Class A Common Stock's annual revenue?

    Inspire Veterinary Partners, Inc. Class A Common Stock reported revenue of $16.59M for the fiscal year ended Dec 31, 2024.

    How fast is Inspire Veterinary Partners, Inc. Class A Common Stock's revenue growing?

    Revenue was down 0.5% for the fiscal year ended Dec 31, 2024 compared with the year before. The compound annual revenue growth rate over 3 years was 86.7%.

    Is Inspire Veterinary Partners, Inc. Class A Common Stock profitable?

    No. Inspire Veterinary Partners, Inc. Class A Common Stock reported net income of -$14.26M for the fiscal year ended Dec 31, 2024, with a net margin of -86.0%.

    How much free cash flow does IVP generate?

    For the fiscal year ended Dec 31, 2024, operating cash flow of -$10.01M minus capital expenditures of $237.98K produced free cash flow of -$10.24M.

    How much debt does Inspire Veterinary Partners, Inc. Class A Common Stock have?

    The balance sheet dated Dec 31, 2024 reported long-term debt of $8.49M, short-term debt of $5.93M and cash and equivalents of $523.69K.